Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Novo Nordisk A S Transaction History

Yahav Achim Ve Achayot Provident Funds Management CO Ltd.

$35.2 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 15, 2023	SELL	$102.55 - $135.33 $933,205 - $1.23 Million	-9,100 Reduced 65.19%	4,860 $657,000
Q3 2021 Nov 17, 2021	BUY	$84.42 - $106.62 $1.18 Million - $1.49 Million	13,960 New	13,960 $1.34 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yahav Achim Ve Achayot Provident Funds Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yahav Achim Ve Achayot Provident Funds Management CO Ltd. with notifications on news.

Account